Friends of Cancer Research Applauds This Nomination
Washington, DC – June 14, 2017 – President Donald Trump has nominated Dr. Norman E. Sharpless to be the next director at the National Cancer Institute (NCI). He will be replacing acting director Dr. Doug Lowy at the largest division within the National Institutes of Health.
“We would like to thank Dr. Lowy for his invaluable service as NCI acting director, and look forward to continuing to work with him as one of our country’s leading cancer scientists,” said Friends of Cancer Research Chairperson, Ellen Sigal. “As we look ahead to the future, we have no doubt that Dr. Sharpless will continue to navigate and direct NCI in a manner that best benefits patients, and we look forward to executing critical work with Dr. Sharpless in his new role.”
Dr. Sharpless is currently the director of the UNC Lineberger Comprehensive Cancer Center and a practicing oncologist specializing in leukemia. Additionally, his research focus has been on the roll the cell cycle plays in cancer and aging. He has authored more than 100 research papers, is an inventor with 10 patents, and is a member of the nation’s oldest honor society for physician-scientists, the American Society of Clinical Investigation.
About Friends of Cancer Research
Friends of Cancer Research (Friends) drives collaboration among partners from every healthcare sector to power advances in science, policy and regulation that speed lifesaving treatments to patients. For more information, please visit www.focr.org.